Quarterly Result11 Aug 2026, 06:32 pm
Syncom Formulations Declares Un-Audited Q1 FY27 Results
AI Summary
Syncom Formulations India Ltd has announced its un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were approved by the Audit Committee and the Board of Directors on August 11, 2026. The company operates in three segments: Pharmaceuticals Drugs & Formulations, Trading of Commodities, and Renting of Property. The financial results will be published in English and Marathi newspapers and filed in XBRL format on the company's website.
Key Highlights
- Un-audited standalone and consolidated financial results declared.
- Results pertain to the quarter ended June 30, 2026.
- Approved by Audit Committee and Board of Directors.
- Company operates in three key business segments.
- Financials to be published and filed in XBRL format.
Price Impact
More from SYNCOMF